Tenax Therapeutics, Inc. Profile Avatar - Palmy Investing

Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that …

Biotechnology
US, Morrisville [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Tenax Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Tenax Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Tenax Therapeutics, Inc..

End of TENX's Analysis
CIK: 34956 CUSIP: 88032L209 ISIN: US88032L6056 LEI: - UEI: -
Secondary Listings
TENX has no secondary listings inside our databases.